BRCA1: The BRCA1 gene was analyzed because it is a common biomarker used to understand the efficacy of chemotherapeutic treatments in patients with breast and ovarian cancers (Quinn et al., 2007; Welcsh & King, 2001). The gene discussed is BRCA1; the disease is ovarian carcinoma.